Obesity-related metabolomic analysis of human subjects in black soybean peptide intervention study by ultraperformance liquid chromatography and quadrupole-time-of-flight mass spectrometry

Journal of Obesity

Volumn 2013, Issue , 2013, Pages

  Kim, Min Jung ^a   Yang, Hye Jeong ^a   Kim, Jin Hee ^a   Ahn, Chang Won ^b   Lee, Jong Ho ^c   Kim, Kang Sung ^d   Kwon, Dae Young ^a  

^a Korea Food Research Institute   (South Korea)

^b Nong Shim Co   (South Korea)

^c Yonsei University   (South Korea)

^d Yongin University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETANILIDE; ANTIOBESITY AGENT; ASPARTYL PHENYLALANINE; BENZOIC ACID; BETAINE; BLACK SOYBEAN PEPTIDE; CARNITINE DERIVATIVE; GLUTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOXANTHINE; ISOLEUCINE; LEUCINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; METHIONINE; PHENYLPYRUVIC ACID; PIPECOLIC ACID; PROLINE; PYROGLUTAMIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID; VALINE; BIOLOGICAL MARKER; VEGETABLE PROTEIN;

ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; OBESITY; PRIORITY JOURNAL; QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WEIGHT REDUCTION; ADULT; AGED; BLOOD; CLINICAL TRIAL; DIET SUPPLEMENTATION; DISCRIMINANT ANALYSIS; DRUG EFFECTS; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; PROCEDURES; REGRESSION ANALYSIS; SOYBEAN; TIME; TREATMENT OUTCOME; YOUNG ADULT; DRUG EFFECT; METHODOLOGY;

ADULT; AGED; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DIETARY SUPPLEMENTS; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; METABOLOMICS; MIDDLE AGED; OBESITY; SOYBEANS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; TREATMENT OUTCOME; VEGETABLE PROTEINS; WEIGHT LOSS; YOUNG ADULT;

EID: 84879329289     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2013/874981     Document Type: Article

References (41)

1. Haslam D. W., James W. P., Obesity. The Lancet 2005 366 9492 1197 1209 (Pubitemid 41393598)
2. Calle E. E., Rodriguez C., Walker-Thurmond K., Thun M. J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. The New England Journal of Medicine 2003 348 17 1625 1638 2-s2.0-0037464510 10.1056/NEJMoa021423 (Pubitemid 36459468)
3. Adams J. P., Murphy P. G., Obesity in anaesthesia and intensive care. British Journal of Anaesthesia 2000 85 1 91 108 2-s2.0-0034130575 (Pubitemid 30417225)
4. Soh J. R., Shin D. H., Kwon D. Y., Cha Y. S., Effect of Cheonggukjang supplementation upon hepatic acyl-CoA synthase, carnitine palmitoyltransferase I, acyl-CoA oxidase and uncoupling protein 2 mRNA levels in C57BL/6J mice fed with high fat diet. Genes and Nutrition 2008 2 4 365 369 2-s2.0-41349110228 10.1007/s12263-007-0066-x (Pubitemid 351447713)
5. Soh J. R., Kwon D. Y., Cha Y. S., Hepatic gene expression profiles are altered by dietary unsalted Korean fermented soybean (Chongkukjang) consumption in mice with diet induced obesity. Journal of Nutrition and Metabolism 2011 2011 10 260214 10.1155/2011/260214
6. Kwon D. Y., Hong S. M., Ahn I. S., Kim M. J., Yang H. J., Park S., Isoflavonoids and peptides from meju, long-term fermented soybeans, increase insulin sensitivity and exert insulinotropic effects in vitro. Nutrition 2011 27 2 244 252 2-s2.0-78650828790 10.1016/j.nut.2010.02.004
7. Yang J. L., Lee S. H., Song Y. S., Improved effect of powders of cooked soybean and chungkukjang on blood pressure and lipid metabolism in spontaneously hypertensive rats. Journal of the Korean Society of Food Science and Nutrition 2003 32 899 905
8. Messina M., Modern applications for an ancient bean: soybeans and the prevention and treatment of chronic disease. Journal of Nutrition 1995 125 3 567 569 2-s2.0-0028890346
9. Young V. R., Soy protein in relation to human protein and amino acid nutrition. Journal of the American Dietetic Association 1991 91 7 828 835 2-s2.0-0025734606
10. Yang H. J., Park S., Pak V., Chung K. R., Kwon D. Y., El-Shemy H. A., Fermented soybean products and their bioactive compounds. Soybean and Health 2011 Rijeka, Croatia Intech 59
11. Nagasawa A., Fukui K., Funahashi T., Maeda N., Shimomura I., Kihara S., Waki M., Takamatsu K., Matsuzawa Y., Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Hormone and Metabolic Research 2002 34 11-12 635 639 2-s2.0-0036875121 10.1055/s-2002-38254 (Pubitemid 36398698)
12. Nagasawa A., Fukui K., Kojuma M., Divergent effects of soy protein diet on the expression of adipocytokines. Biochemical and Biophysical Research Communications 2003 311 4 909 914 (Pubitemid 37393404)
13. Kwak J. H., Lee J. H., Ahn C. W., Park S. H., Shim S. T., Song Y. D., Han E. N., Lee K. H., Chae J. S., Black soy peptide supplementation improves glucose control in subjects with prediabetes and newly diagnosed type 2 diabetes mellitus. Journal of Medicinal Food 2010 13 6 1307 1312 2-s2.0-79953038841
14. Kim H. J., Bae I. Y., Ahn C. W., Lee S., Lee H. G., Purification and identification of adipogenesis inhibitory peptide from black soybean protein hydrolysate. Peptides 2007 28 11 2098 2103 2-s2.0-35348991559 10.1016/j.peptides.2007.08.030 (Pubitemid 47600417)
15. Kwak J. H., Ahn C. W., Park S. H., Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study. Food and Nutrition 2012 3 10 1019 1024
16. Puski G., Modification of functional properties of soy proteins by proteolytic enzyme treatment. Cereal Chemistry 1975 52 655 664
17. Kim H. J., Kim J. H., Noh S., Hur H. J., Sung M. J., Hwang J. T., Park J. H., Yang H. J., Kim M. S., Kwon D. Y., Yoon S. H., Metabolomic analysis of livers and serum from high-fat diet induced obese mice. Journal of Proteome Research 2011 10 2 722 731 2-s2.0-79955433960 10.1021/pr100892r
18. Kwon D. Y., Oh S. W., Lee J. S., Yang H. J., Lee S. H., Lee J. H., Amino acid substitution of hypocholesterolemic peptide originated from glycinin hydrolyzate. Food Science and Biotechnology 2002 11 55 61
19. Kim J. Y., Park J. Y., Kim O. Y., Ham B. M., Kim H. J., Kwon D. Y., Jang Y., Lee J. H., Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF Mass spectrometry (UPLC-Q-TOF MS). Journal of Proteome Research 2010 9 9 4368 4375 2-s2.0-77956299196 10.1021/pr100101p
20. Dunn W. B., Broadhurst D., Begley P., Zelena E., Francis-Mcintyre S., Anderson N., Brown M., Knowles J. D., Halsall A., Haselden J. N., Nicholls A. W., Wilson I. D., Kell D. B., Goodacre R., Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols 2011 6 7 1060 1083 2-s2.0-79959913950 10.1038/nprot.2011.335
21. Rho S. J., Park S., Ahn C.-W., Shin J.-K., Lee H. G., Dietetic and hypocholesterolaemic action of black soy peptide in dietary obese rats. Journal of the Science of Food and Agriculture 2007 87 5 908 913 2-s2.0-34147093109 10.1002/jsfa.2808 (Pubitemid 46570323)
22. Jang E. H., Moon J. S., Ko J. H., Ahn C.-W., Lee H.-H., Shin J.-K., Park C.-S., Kang J.-H., Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase. International Journal of Obesity 2008 32 7 1161 1170 2-s2.0-47249161117 10.1038/ijo.2008.60 (Pubitemid 351986205)
23. Allison D. B., Gadbury G., Schwartz L. G., Murugesan R., Kraker J. L., Heshka S., Fontaine K. R., Heymsfield S. B., A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. European Journal of Clinical Nutrition 2003 57 4 514 522 2-s2.0-0038743003 10.1038/sj.ejcn.1601587 (Pubitemid 36553590)
24. Galili O., Versari D., Sattler K. J., Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. American Journal of Physiology-Heart and Circulatory Physiology 2007 292 2 H904 H911
25. Aiyar N., Disa J., Ao Z., Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Molecular and Cellular Biochemistry 2007 295 1-2 113 120 (Pubitemid 46157993)
26. Schmitz G., Ruebsaamen K., Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 2010 208 1 10 18 2-s2.0-73449097463 10.1016/j.atherosclerosis.2009.05.029
27. Croset M., Brossard N., Polette A., Lagarde M., Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochemical Journal 2000 345 1 61 67 2-s2.0-0033983832 10.1042/0264-6021:3450061 (Pubitemid 30060104)
28. Nelson A. M., Phospholipids and coronary mortality. Use of ratio between phospholipid and cholesterol levels to determine successful treatment. Northwest Medical 1962 61 47 52
29. Pietiläinen K. H., Sysi-Aho M., Rissanen A., Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study. PLos One 2007 2 2, article e218
30. Craig S. A., Betaine in human nutrition American. Journal of Clinical Nutrition 2004 80 3 539 549
31. Sugiyama K., Akai H., Muramatsu K., Effects of methionine and related compounds on plasma cholesterol level in rats fed a high cholesterol diet. Journal of Nutritional Science and Vitaminology 1986 32 5 537 549 2-s2.0-0022789132
32. Turpin P., A double blind study of the effectiveness of Beaufor betaine citrate ampules in the treatment of type IV hyperlipidemias. Sem Hop 1985 61 2420 2434
33. Odle J., Betaine and carnitine. Feed Manage 1996 47 25 27
34. Steiber A., Kerner J., Hoppel C. L., Carnitine: a nutritional, biosynthetic, and functional perspective. Molecular Aspects of Medicine 2004 25 5-6 455 473 2-s2.0-4444315751 10.1016/j.mam.2004.06.006 (Pubitemid 39195071)
35. Rinaldo P., Cowan T. M., Matern D., Acylcarnitine profile analysis. Genetics in Medicine 2008 10 2 151 156 (Pubitemid 351271727)
36. Mun E. G., Soh J. R., Cha Y. S., L-carnitine reduces obesity caused by high-fat diet in C57BL/6J mice. Food Science and Biotechnology 2007 16 2 228 233 2-s2.0-44649165298
37. Cha Y. S., Soh J. R., Kim C. K., Park H., Effect of carnitine and antioxidant supplementation on carnitine and lipid profiles in trained and non-trained humans. The FASEB Journal 2003 17 supplement 1 A733 A744
38. Yang J. Y., Lee S. J., Park H. W., Cha Y. S., Effect of genistein with carnitine administration on lipid parameters and obesity in C57B1/6J mice fed a high-fat diet. Journal of Medicinal Food 2006 9 4 459 467 2-s2.0-33846235519
39. Jensen M. D., Haymond M. W., Protein metabolism in obesity: effects of body fat distribution and hyperinsulinemia on leucine turnover. American Journal of Clinical Nutrition 1991 53 1 172 176 2-s2.0-0026056770 (Pubitemid 21917627)
40. Lin S. D., Tsai D. H., Hsu S. R., Association between serum uric acid level and components of the metabolic syndrome. Journal of the Chinese Medical Association 2006 69 11 512 516 2-s2.0-33845895003
41. Son N., Hur H. J., Sung M. J., Liquid chromatography-mass spectrometry-based metabolomic analysis of livers from aged rats. Journal of Proteome Research 2012 11 4 2551 2558